CAPIVASERTIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 28 adverse event reports in the FDA FAERS database where CAPIVASERTIB was used for Neoplasm malignant.
Most Reported Side Effects for CAPIVASERTIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 278 | 16.4% | 11 | 88 |
| Rash | 253 | 15.0% | 3 | 64 |
| Death | 228 | 13.5% | 221 | 10 |
| Hyperglycaemia | 152 | 9.0% | 16 | 71 |
| Nausea | 96 | 5.7% | 5 | 34 |
| Vomiting | 81 | 4.8% | 7 | 34 |
| Blood glucose increased | 70 | 4.1% | 5 | 31 |
| Fatigue | 67 | 4.0% | 5 | 18 |
| Malignant neoplasm progression | 62 | 3.7% | 11 | 13 |
| Disease progression | 61 | 3.6% | 1 | 2 |
| Pyrexia | 55 | 3.3% | 1 | 31 |
| Diabetic ketoacidosis | 52 | 3.1% | 21 | 39 |
| Decreased appetite | 46 | 2.7% | 7 | 20 |
| Dehydration | 45 | 2.7% | 5 | 29 |
| Urinary tract infection | 43 | 2.5% | 5 | 16 |
Other Indications for CAPIVASERTIB
Breast cancer female (395)
Breast cancer (287)
Breast cancer metastatic (182)
Product used for unknown indication (50)
Breast cancer recurrent (36)
Her2 negative breast cancer (12)
Breast cancer stage iv (11)
Her2 positive breast cancer (11)
Hormone receptor positive breast cancer (11)
Hormone-dependent prostate cancer (7)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)